This research investigates the extent to which financial incentives (conditional cash transfers) would induce Americans to opt for vaccination against coronavirus disease of 2019. We performed a randomized survey experiment with a representative sample of 1000 American adults in December 2020. Respondents were asked whether they would opt for vaccination under one of three incentive conditions ($1000, $1500, or $2000 financial incentive) or a no-incentive condition. We find that - without coupled financial incentives - only 58 per cent of survey respondents would elect for vaccination. A coupled financial incentive yields an 8-percentage-point increase in vaccine uptake relative to this baseline. The size of the cash transfer does not drama...
As rates of vaccination have slowed, concerns are growing about how to increase vaccine uptake among...
Various efforts to increase COVID-19 vaccination rates have been employed in the United States. We s...
While efficacious vaccines have been developed to inoculate against severe acute respiratory syndrom...
This research investigates the extent to which financial incentives (conditional cash transfers) wou...
Abstract Background More than two years into the coronavirus disease (COVID-19) pandemic, it remains...
Experts debate whether COVID-19 vaccine mandates or financial incentives will reduce, rather than in...
Stalling COVID-19 vaccination rates threaten public health. To increase vaccination rates, governmen...
When the US expanded COVID-19 vaccine eligibility to all adults, many state governments developed ca...
Financial incentives to encourage healthy and prosocial behaviours often trigger initial behavioural...
Monetary incentives to increase COVID-19 vaccinations are widely used. Even if they work, whether s...
Objectives: Amid a pandemic, vaccines represent a promising solution for mitigating public health an...
IntroductionAlthough vaccination is the most effective way to limit and overcome the COVID-19 pandem...
IntroductionAlthough vaccination is the most effective way to limit and overcome the COVID-19 pandem...
Herd immunity against Covid-19 demands a high rate of vaccination, which may be challenging to meet ...
Monetary and legal incentives have been proposed to promote COVID-19 vaccination uptake. To evaluate...
As rates of vaccination have slowed, concerns are growing about how to increase vaccine uptake among...
Various efforts to increase COVID-19 vaccination rates have been employed in the United States. We s...
While efficacious vaccines have been developed to inoculate against severe acute respiratory syndrom...
This research investigates the extent to which financial incentives (conditional cash transfers) wou...
Abstract Background More than two years into the coronavirus disease (COVID-19) pandemic, it remains...
Experts debate whether COVID-19 vaccine mandates or financial incentives will reduce, rather than in...
Stalling COVID-19 vaccination rates threaten public health. To increase vaccination rates, governmen...
When the US expanded COVID-19 vaccine eligibility to all adults, many state governments developed ca...
Financial incentives to encourage healthy and prosocial behaviours often trigger initial behavioural...
Monetary incentives to increase COVID-19 vaccinations are widely used. Even if they work, whether s...
Objectives: Amid a pandemic, vaccines represent a promising solution for mitigating public health an...
IntroductionAlthough vaccination is the most effective way to limit and overcome the COVID-19 pandem...
IntroductionAlthough vaccination is the most effective way to limit and overcome the COVID-19 pandem...
Herd immunity against Covid-19 demands a high rate of vaccination, which may be challenging to meet ...
Monetary and legal incentives have been proposed to promote COVID-19 vaccination uptake. To evaluate...
As rates of vaccination have slowed, concerns are growing about how to increase vaccine uptake among...
Various efforts to increase COVID-19 vaccination rates have been employed in the United States. We s...
While efficacious vaccines have been developed to inoculate against severe acute respiratory syndrom...